Anthology Diagnostics is the first lab to utilize GTC’s cooperative business model to internalize their next-gen sequencing testing for oncology analyzing DNA and RNA. Anthology Diagnostics was opened with the vision of providing comprehensive genomic profiling to the Hackensack Meridian Health cancer patient population; and to serve physicians and labs within the greater NJ area.
Learn how you can internalize your NGS testing for oncology.
The cooperative business model allows labs to share resources, best practices, data and help each other with publications studies. The goal is to provide a more collaborative business model, drive down the cost of testing and improve quality/standardization of testing.
Both labs offer standardized comprehensive genomic profiling covering both solid tumors and hematologic neoplasms, including a robust liquid biopsy option.
Patients who undergo testing will be given a precision diagnosis of their disease and subclassification. They will be given the best chance to be matched to a precision medicine based on their tumor’s signature or enrolled in a clinical trial. Most importantly patients will be contributing to the knowledge base of cancer to help everyone who gets a cancer diagnosis